ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

Why Fibrosis is on this study

  • ClinicalTrials.gov files the study under Fibrosis.
  • GPT-6 Astra (Medium) judged the term about another subject. Oct 20 (day only)
  • It is the study's main condition, by the main-condition rule: the study is compared with others under Fibrosis.
1 links0 made here, not in the record2 judgments2 judges (the rules as one: Rule based)1 record change seen
GPT-6 Astra (Medium)Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT06948656Study of the Impact ofHYPOglycaemia on Sarcopeniain CIRrhosisCentre Hospitalier UniversitairecruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 20 · ClinicalTrials.gov record · Version of 2026-11-20Version of 2026-11-20CONDITIONSFibrosisThe registry's MeSH filing›Oct 20 · GPT-6 Astra (Medium) · Another subject: Sarcopenia + HypoglycemiaAs of now · Rule based · Main conditionMain condition

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
1 version of the record seen on ClinicalTrials.gov, Nov 20 · changes seen, not judgments
Oct 20FibrosisGPT-6 Astra (Medium)Another subject: Sarcopenia + HypoglycemiaCurrent
As of nowFibrosisRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.